DeFi Technologies Class Action: Levi & Korsinsky Reminds DeFi Technologies Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 30, 2026 – DEFT

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in DeFi Technologies (“DeFi Technologies” or the “Company”) (NASDAQ: DEFT) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of DeFi Technologies investors who were adversely affected by alleged securities fraud between May 12, 2025 and November 14, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/defi-technologies-lawsuit-submission-form?prid=181818&wire=3

DEFT investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) DeFi Technologies was facing delays in executing its DeFi arbitrage strategy, which at all relevant times was a key revenue driver for the Company; (ii) DeFi Technologies had understated the extent of competition it faced from other digital asset treasury companies and the extent to which that competition would negatively impact its ability to execute its DeFi arbitrage strategy; (iii) as a result of the foregoing issues, the Company was unlikely to meet its previously issued revenue guidance for the fiscal year 2025; (iv) accordingly, defendants had downplayed the true scope and severity of the negative impact that the foregoing issues were having on DeFi Technologies’ business and financial results; and (v) as a result, defendants’ public statements were materially false and misleading at all relevant times.

WHAT’S NEXT? If you suffered a loss in DeFi Technologies during the relevant time frame, you have until January 30, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



StubHub Holdings, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – STUB

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in StubHub Holdings, Inc. (“StubHub Holdings, Inc.” or the “Company”) (NYSE: STUB) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of StubHub Holdings, Inc. investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired StubHub common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s September 2025 initial public offering. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/stubhub-holdings-inc-lawsuit-submission-form?prid=181817&wire=3

STUB investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the Company was experiencing changes in the timing of payments to vendors; (2) those changes had a significant adverse impact on free cash flow, including trailing 12 months free cash flow; (3) as a result, the Company’s free cash flow reports were materially misleading; and (4) that, as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

WHAT’S NEXT? If you suffered a loss in StubHub Holdings, Inc. during the relevant time frame, you have until January 23, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com 



Shareholders that lost money on Blue Owl Capital Inc.(OWL) should contact Levi & Korsinsky about pending Class Action – OWL

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) —  Levi & Korsinsky, LLP notifies investors in Blue Owl Capital Inc. (“Blue Owl Capital Inc.” or the “Company”) (NYSE: OWL) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Blue Owl Capital Inc. investors who were adversely affected by alleged securities fraud between February 6, 2025 and November 16, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/blue-owl-capital-inc-lawsuit-submission-form?prid=181816&wire=3 

OWL investors may also contact Joseph E. Levi, Esq. via email at [email protected]  or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Blue Owl was experiencing a meaningful pressure on its asset base from business development companies’ redemptions; (2) as a result, the Company was facing undisclosed liquidity issues; (3) as a result, the Company would be likely to limit or halt redemptions of certain business development companies; and (4) as a result of the foregoing, defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

WHAT’S NEXT? If you suffered a loss in Blue Owl Capital Inc. during the relevant time frame, you have until February 2, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com 



Primo Brands Corporation / Primo Water Corporation Sued for Securities Law Violations – Contact Levi & Korsinsky Before January 12, 2026 to Discuss Your Rights – PRMB

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Primo Brands Corporation / Primo Water Corporation (“Primo Brands Corporation / Primo Water Corporation” or the “Company”) (NYSE: PRMB) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Primo Brands Corporation / Primo Water Corporation investors who were adversely affected by alleged securities fraud between June 17, 2024 and November 6, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/primo-brands-corporation-primo-water-corporation-lawsuit-submission-form?prid=181815&wire=3

PRMB investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: According to the filed complaint, defendants made false statements and/or concealed that the merger integration between Primo Water and BlueTriton Brands was tracking poorly due to, among other things, technology and service issues. Moreover—and contrary to defendants’ statements assuring investors that the execution was “flawless”—Primo Brands was having major supply disruptions which would negatively impact customers and thus Primo Brands’ financial results.

WHAT’S NEXT? If you suffered a loss in Primo Brands Corporation / Primo Water Corporation during the relevant time frame, you have until January 12, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX) Seeking Recovery for Investors – Contact Levi & Korsinsky

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) — Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. (“Telix Pharmaceuticals Ltd.” or the “Company”) (NASDAQ: TLX) of a class action securities lawsuit.

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Telix Pharmaceuticals Ltd. investors who were adversely affected by alleged securities fraud between February 21, 2025 and August 28, 2025. Follow the link below to get more information and be contacted by a member of our team:

https://zlk.com/pslra-1/telix-pharmaceuticals-ltd-lawsuit-submission-form?prid=181814&wire=3

TLX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500.

CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) defendants materially overstated the progress Telix had made with regard to prostate cancer therapeutic candidates; (2) defendants materially overstated the quality of Telix’s supply chain and partners; and (3) as a result, defendants’ statements about Telix’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

WHAT’S NEXT? If you suffered a loss in Telix Pharmaceuticals Ltd. during the relevant time frame, you have until January 9, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.

WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected] 
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com



Northern Trust Corporation to Webcast Fourth Quarter 2025 Earnings Conference Call

Northern Trust Corporation to Webcast Fourth Quarter 2025 Earnings Conference Call

CHICAGO–(BUSINESS WIRE)–
Northern Trust Corporation announced today that it will webcast its fourth quarter 2025 earnings conference call live on Thursday, January 22, 2026. The webcast, the earnings press release, and related presentation materials will be accessible on Northern Trust’s website.

The call will be conducted at 8:00 a.m. (CT), following the release that morning of Northern Trust’s fourth quarter 2025 earnings press release. A replay of the webcast will be available for approximately four weeks after the date of the call.

About Northern Trust

Northern Trust Corporation (Nasdaq: NTRS) is a leading provider of wealth management, asset servicing, asset management and banking services to corporations, institutions, affluent families and individuals. Founded in Chicago in 1889, Northern Trust has a global presence with offices in 24 U.S. states and Washington, D.C., and across 22 locations in Canada, Europe, the Middle East and the Asia-Pacific region. As of September 30, 2025, Northern Trust had assets under custody/administration of US$18.2 trillion, and assets under management of US$1.8 trillion. For more than 135 years, Northern Trust has earned distinction as an industry leader for exceptional service, financial expertise, integrity and innovation. Visit us on northerntrust.com. Follow us on Instagram @northerntrustcompany or Northern Trust on LinkedIn.

Northern Trust Corporation, Head Office: 50 South La Salle Street, Chicago, Illinois 60603 U.S.A., incorporated with limited liability in the U.S. Global legal and regulatory information can be found at https://www.northerntrust.com/terms-and-conditions

Investor Contact:

Jennifer Childe

(312) 444-3290

[email protected]

Media Contact:

John D. O’Connell

(312) 444-2388

John.O’[email protected]

http://www.northerntrust.com

KEYWORDS: Illinois United States North America

INDUSTRY KEYWORDS: Professional Services Other Professional Services Finance Asset Management Banking Personal Finance

MEDIA:

Logo
Logo

Penumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference

PR Newswire

ALAMEDA, Calif., Dec. 29, 2025 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026.


Event:

 44th Annual J.P. Morgan Healthcare Conference


Date:

 Monday, January 12, 2026


Time:

 6:45pm ET/3:45pm PT

A webcast of the presentation can be accessed on the “Events and Presentations” section under the “Investors” tab of the company’s website at www.penumbrainc.com. The webcast will be available on the company’s website for at least two weeks following the event.

About Penumbra
Penumbra, Inc., the world’s leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.

Investor Relations

Penumbra, Inc.
[email protected] 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302640354.html

SOURCE Penumbra, Inc.

Cadence Bank Announces Fourth Quarter 2025 and Annual Financial Results Distribution Schedule

PR Newswire

HOUSTON and TUPELO, Miss., Dec. 29, 2025 /PRNewswire/ — Cadence Bank (NYSE: CADE) will release its fourth quarter 2025 earnings and annual financial results on Thursday, January 22, 2026, prior to the opening of the financial markets. The release will be found on the company’s investor relations website and distributed on PR Newswire.

About Cadence Bank

Cadence Bank (NYSE: CADE) is a $53 billion regional bank committed to helping people, companies and communities prosper. With more than 390 locations spanning the South and Texas, Cadence offers comprehensive banking, investment, trust and mortgage products and services to meet the needs of individuals, businesses and corporations. Accolades include being recognized as one of the nation’s best employers by Forbes and U.S. News & World Report and as a 2025 America’s Best Banks by Forbes. Cadence has dutifully served customers for nearly 150 years. Learn more at www.cadencebank.com. Cadence Bank, Member FDIC. Equal Housing Lender.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cadence-bank-announces-fourth-quarter-2025-and-annual-financial-results-distribution-schedule-302648120.html

SOURCE Cadence Bank

Nexxen Announces Postponement of 2025 Annual General Meeting – Meeting Rescheduled for January 6, 2026

NEW YORK, Dec. 29, 2025 (GLOBE NEWSWIRE) — Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that it is postponing the date of its 2025 Annual General Meeting of Shareholders (the “AGM”), originally scheduled for December 30, 2025, in order to give shareholders sufficient opportunity to consider the proposals presented in the Amended and Restated Proxy Statement published on November 26, 2025, as updated by the Supplemental Proxy Statement published on December 26, 2025 (as supplemented, the “Proxy Statement”), and to provide adequate time for the receipt and processing of shareholder votes in light of recent and upcoming market holidays.

The AGM will take place instead on January 6, 2026, at 3:30 p.m. Israel time, at the Company’s offices at 82 Yigal Alon Street, Tel Aviv 6789124, Israel.

The AGM proposals outlined in the Proxy Statement remain unchanged and the originally declared record date of the AGM, December 1, 2025, remains unchanged.

The Board of Directors recommends that shareholders vote in favor of (“FOR”) all AGM proposals and urges shareholders to vote so that their votes will be counted at the AGM or at any postponements or adjournments of the AGM.

The deadline for submitting votes for the postponed AGM has been extended to 11:59 p.m. EDT on January 5, 2026 (the “Voting Deadline”). The Company will not be able to count a proxy card unless it is received at the Company’s offices at 82 Yigal Alon Street, Tel Aviv 6789124, Israel, or Computershare receives it in the enclosed envelope, no later than the Voting Deadline.

The Company will count towards the tally of votes for the AGM all proxy cards or voting instruction forms that have already been properly completed and submitted. Accordingly, a shareholder who already submitted a proxy card or voting instruction form is not required to resubmit such form unless such shareholder elects to resubmit a new proxy card or voting instruction form, in which case the new submission will replace the original vote.

The Proxy Statement (as supplemented), which includes full details regarding the AGM proposals and AGM logistics, is available for review under the “Annual Reports & Circulars” section of Nexxen’s investor relations website at https://investors.nexxen.com/, and has been furnished to the U.S. Securities and Exchange Commission under cover of Form 6-K.


About Nexxen

Nexxen empowers advertisers, agencies, publishers and broadcasters around the world to utilize data and advanced TV in the ways that are most meaningful to them. Our flexible and unified technology stack comprises a demand-side platform (“DSP”) and supply-side platform (“SSP”), with the Nexxen Data Platform at its core. With streaming in our DNA, Nexxen’s robust capabilities span discovery, planning, activation, monetization, measurement and optimization – available individually or in combination – all designed to enable our partners to achieve their goals, no matter how far-reaching or hyper niche they may be.

Nexxen is headquartered in Israel and maintains offices throughout the United States, Canada, Europe and Asia-Pacific, and is traded on Nasdaq (NEXN). For more information, visit www.nexxen.com.


Forward Looking Statements

This press release contains forward-looking statements, including forward-looking statements within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities and Exchange Act of 1934, as amended. Forward-looking statements are identified by words such as “anticipates,” “believes,” “expects,” “intends,” “may,” “can,” “will,” “estimates,” and other similar expressions. However, these words are not the only way Nexxen identifies forward-looking statements. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements. These statements are neither promises nor guarantees but involve known and unknown risks, uncertainties and other important factors that may cause Nexxen’s actual results, performance or achievements to be materially different from its expectations expressed or implied by the forward-looking statements, including, but not limited to, the following: negative global economic conditions, including risks related to tariff impacts or policy shifts (including trade negotiations or enforcement actions) that could materially affect market sentiment, consumer behavior and advertising demand; global conflicts and war, including the war and hostilities between Israel and Hamas, Hezbollah, the Houthis in Yemen and Iran, and how those conditions may adversely impact Nexxen’s business, customers and the markets in which Nexxen competes; changes in industry trends; and other negative developments in Nexxen’s business or unfavorable legislative or regulatory developments. Nexxen cautions you not to place undue reliance on these forward-looking statements. For a more detailed discussion of these factors, and other factors that could cause actual results to vary materially, interested parties should review the risk factors listed in the Company’s most recent Annual Report on Form 20-F, filed with the U.S. Securities and Exchange Commission (www.sec.gov) on March 5, 2025. Any forward-looking statements made by Nexxen in this press release speak only as of the date of this press release, and Nexxen does not intend to update these forward-looking statements after the date of this press release, except as required by law.

Nexxen, and the Nexxen logo are trademarks of Nexxen International Ltd. in the United States and other countries. All other trademarks are the property of their respective owners. The use of the word “partner” or “partnership” in this press release does not mean a legal partner or legal partnership.

For further information please contact:

Nexxen International Ltd.

Billy Eckert, Vice President of Investor Relations
[email protected]

Caroline Smith, Vice President of Communications
[email protected]



iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

SAN FRANCISCO, Dec. 29, 2025 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference.

iRhythm’s management is scheduled to present on Monday, January 12, 2026, at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Events and Presentations” section of the company’s investor website at investors.irhythmtech.com.

About iRhythm Technologies, Inc.

iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Relations Contact

Stephanie Zhadkevich
[email protected]

Media Contact

Kassandra Perry
[email protected]